Therefore, it would appear that Bscl2 loss in hepatocytes does not play a significant role in the development of hepatic steatosis or glucose intolerance in seipin-deficient states, even on a background of generalised lipodystrophy. This evidence concerns the gene BSCL2 and fatty liver disease.